Eloctate, Antihemophilic Factor receives FDA approval for treatment of Hemophilia A

The U.S. Food and Drug Administration today approved Eloctate, Antihemophilic Factor (Recombinant), Fc fusion protein, for use in adults and children who have Hemophilia A. Eloctate is the first Hemophilia A treatment designed to require less frequent injections when used to prevent or reduce the frequency of bleeding. Eloctate is approved to help control More...

by deskofbrian | Published 3 months ago
By deskofbrian On Thursday, June 5th, 2014
1 Comment

E-cigarettes advertisements directed toward youth increase significantly: study

PRESS RELEASE RESEARCH TRIANGLE PARK, N.C.— In the absence of the kind of federal regulations that apply to tobacco cigarettes, television advertising for e-cigarettes has increased two-fold for youth and three-fold More...

By deskofbrian On Thursday, June 5th, 2014
0 Comments

Yogurt Covered Craisins recalled due to undeclared peanuts

PRESS RELEASE Ocean Spray today announced it has taken the precautionary measure of voluntarily recalling two production lots of Ocean Spray® Greek Yogurt Covered Craisins® Dried Cranberries because the products More...

By deskofbrian On Tuesday, June 3rd, 2014